The proteasorne and MHC class I antigen processing

被引:140
作者
Kloetzel, PM [1 ]
机构
[1] Humboldt Univ, Inst Biochem, Charite, Fak Med, D-10117 Berlin, Germany
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2004年 / 1695卷 / 1-3期
关键词
proteasome; immune response; antigen presentation; MHC-complex; intereferon-gamma; interferon; antigen processing;
D O I
10.1016/j.bbamcr.2004.10.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
By generating peptides from intracellular antigens, which are then presented to T cells, the ubiquitin/26S proteasome system plays a central role in the cellular immune response. Under the control of interferon-gamma the proteolytic properties of the proteasome are adapted to the requirements of the immune system. Interferon-gamma induces the formation of immunoproteasomes and the synthesis of the proteasome activator PA28. Both alter the proteolytic properties of the proteasome complex and enhance proteasomal function in antigen presentation. Thus. a combination of several of regulatory events tunes the proteasome system for maximal efficiency in the generation of MHC class I antigens. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 113 条
[81]   An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides [J].
Saric, T ;
Chang, SC ;
Hattori, A ;
York, IA ;
Markant, S ;
Rock, KL ;
Tsujimoto, M ;
Goldberg, AL .
NATURE IMMUNOLOGY, 2002, 3 (12) :1169-1176
[82]   Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases [J].
Saveanu, L ;
Fruci, D ;
van Endert, PM .
MOLECULAR IMMUNOLOGY, 2002, 39 (3-4) :203-215
[83]   THE HPV-16 E6 AND E6-AP COMPLEX FUNCTIONS AS A UBIQUITIN-PROTEIN LIGASE IN THE UBIQUITINATION OF P53 [J].
SCHEFFNER, M ;
HUIBREGTSE, JM ;
VIERSTRA, RD ;
HOWLEY, PM .
CELL, 1993, 75 (03) :495-505
[84]   Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein [J].
Schmidtke, G ;
Eggers, M ;
Ruppert, T ;
Groettrup, M ;
Koszinowski, UH ;
Kloetzel, PM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1641-1646
[85]   Rapid degradation of a large fraction of newly synthesized proteins by proteasomes [J].
Schubert, U ;
Antón, LC ;
Gibbs, J ;
Norbury, CC ;
Yewdell, JW ;
Bennink, JR .
NATURE, 2000, 404 (6779) :770-774
[86]   Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28α/β, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope [J].
Schwarz, K ;
van den Broek, M ;
Kostka, S ;
Kraft, R ;
Soza, A ;
Schmidtke, G ;
Kloetzel, PM ;
Groettrup, M .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :768-778
[87]   HIV-1 Tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation [J].
Seeger, M ;
Ferrell, K ;
Frank, R ;
Dubiel, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8145-8148
[88]   An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope [J].
Seifert, U ;
Marañón, C ;
Shmueli, A ;
Desoutter, JF ;
Wesoloski, L ;
Janek, K ;
Henklein, P ;
Diescher, S ;
Andrieu, M ;
de la Salle, H ;
Weinschenk, T ;
Schild, H ;
Laderach, D ;
Galy, A ;
Haas, G ;
Kloetzel, PM ;
Reiss, Y ;
Hosmalin, A .
NATURE IMMUNOLOGY, 2003, 4 (04) :375-379
[89]  
Seliger B, 1996, CANCER RES, V56, P1756
[90]  
Seliger B, 2001, CANCER RES, V61, P1095